Literature DB >> 17220299

Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha.

Jie Zhou1, Anastassios E Damdimopoulos, Giannis Spyrou, Bernhard Brüne.   

Abstract

Hypoxia inducible factor 1 (HIF-1), a key regulator for adaptation to hypoxia, is composed of HIF-1alpha and HIF-1beta. In this study, we present evidence that overexpression of mitochondria-located thioredoxin 2 (Trx2) attenuated hypoxia-evoked HIF-1alpha accumulation, whereas cytosolic thioredoxin 1 (Trx1) enhanced HIF-1alpha protein amount. Transactivation of HIF-1 is decreased by overexpression of Trx2 but stimulated by Trx1. Inhibition of proteasomal degradation of HIF-1alpha in Trx2-overexpressing cells did not fully restore HIF-1alpha protein levels, while HIF-1alpha accumulation was enhanced in Trx1-overexpressing cells. Reporter assays showed that cap-dependent translation is increased by Trx1 and decreased by Trx2, whereas HIF-1alpha mRNA levels remained unaltered. These data suggest that thioredoxins affect the synthesis of HIF-1alpha. Trx1 facilitated synthesis of HIF-1alpha by activating Akt, p70S6K, and eIF-4E, known to control cap-dependent translation. In contrast, Trx2 attenuated activities of Akt, p70S6K, and eIF-4E and provoked an increase in mitochondrial reactive oxygen species production. MitoQ, a mitochondria specific antioxidant, reversed HIF-1alpha accumulation as well as Akt activation under hypoxia in Trx2 cells, supporting the notion of translation control mechanisms in affecting HIF-1alpha protein accumulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220299     DOI: 10.1074/jbc.M608289200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.

Authors:  Ram Sudheer Adluri; Mahesh Thirunavukkarasu; Lijun Zhan; Yuzo Akita; Samson Mathews Samuel; Hajime Otani; Ye-Shih Ho; Gautam Maulik; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2010-11-11       Impact factor: 5.000

Review 2.  Hyperbaric oxygen, vasculogenic stem cells, and wound healing.

Authors:  Katina M Fosen; Stephen R Thom
Journal:  Antioxid Redox Signal       Date:  2014-05-19       Impact factor: 8.401

Review 3.  Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

Authors:  D Lynn Kirkpatrick; Garth Powis
Journal:  Antioxid Redox Signal       Date:  2016-04-22       Impact factor: 8.401

Review 4.  Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies.

Authors:  Changgong Wu; Andrew M Parrott; Cexiong Fu; Tong Liu; Stefano M Marino; Vadim N Gladyshev; Mohit R Jain; Ahmet T Baykal; Qing Li; Shinichi Oka; Junichi Sadoshima; Annie Beuve; William J Simmons; Hong Li
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

5.  A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers.

Authors:  A F Baker; T Dragovich; K N Adab; N Raghunand; Hhs Chow; S P Stratton; S W Squire; M Boice; L A Pestano; D L Kirkpatrick
Journal:  Invest New Drugs       Date:  2012-06-19       Impact factor: 3.850

6.  Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes.

Authors:  Lorella Marselli; Jeffrey Thorne; Sonika Dahiya; Dennis C Sgroi; Arun Sharma; Susan Bonner-Weir; Piero Marchetti; Gordon C Weir
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

Review 7.  Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia-reperfusion injury.

Authors:  Jun Yoshioka; Richard T Lee
Journal:  Trends Cardiovasc Med       Date:  2013-07-26       Impact factor: 6.677

Review 8.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

9.  Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status.

Authors:  Salvador Naranjo-Suarez; Bradley A Carlson; Ryuta Tobe; Min-Hyuk Yoo; Petra A Tsuji; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Mol Cells       Date:  2013-08-01       Impact factor: 5.034

10.  3,3'-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells.

Authors:  Jacques E Riby; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.